About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Med
›
Top Articles
Med
31.7
(top 1%)
Impact Factor
32.8
(top 1%)
extended IF
20
(top 17%)
H-Index
319
authors
175
papers
1.8K
citations
388
citing journals
2.3K
citing authors
Most Cited Articles of Med
Title
Year
Citations
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
2020
315
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
2020
180
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis
2021
154
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
2021
110
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection
2021
74
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
2021
70
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset
2021
56
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19
2020
51
Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface
2021
43
When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?
2020
41
Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes
2021
38
A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children
2021
38
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study
2020
30
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice
2021
25
Primary human colonic mucosal barrier crosstalk with super oxygen-sensitive in continuous culture
2021
25
Alterations in T and B cell function persist in convalescent COVID-19 patients
2021
22
Regulatory and Safety Considerations in Deploying a Locally Fabricated, Reusable Face Shield in a Hospital Responding to the COVID-19 Pandemic
2020
20
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
2021
20
Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy
2021
17
Kidney Function Indicators Predict Adverse Outcomes of COVID-19
2021
17
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
2020
15
The Interpretation of SARS-CoV-2 Diagnostic Tests
2020
15
Fatal perinatal mitochondrial cardiac failure caused by recurrent duplications in the locus
2021
15
The Assessment of Convalescent Plasma Efficacy against COVID-19
2020
14
Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity
2021
13
previous
2019
2020
2021
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.